Cancer specialists are always looking for better ways to treat lung cancer, including the oncologists at Rocky Mountain Cancer Centers. Clinical trials are the primary way to make scientific advances in the available treatment options. Every cancer treatment today is the result of clinical research conducted earlier. Today, cancer patients lead longer and healthier lives because of improved treatments with better outcomes than ever before!
RMCC recognizes the importance of cancer research and plays a role in helping lung cancer patients, as well as other types of cancer patients, identify and research treatments. Due to this importance, we offer clinical trials and research to our patients for lung and other types of cancer. We are partnered with US Oncology Research, a clinical research organization that makes it possible to bring many important clinical trials to our patients in Colorado.
Every clinical trial, including those for lung cancer, has a set of specific protocols that must be followed precisely. The protocol is reviewed and approved by scientific experts and an institutional review board (IRB) before it begins and throughout the period the trial is run.
The clinical trial protocol explains the purpose, requirements, methodologies, and different clinical trial phases. Cancer patients who meet the requirements mentioned in the protocol are eligible to participate in the clinical trial.
Each clinical trial will have requirements based on factors such as:
Patients are only added to a clinical trial after going through an explanation and approval process. If one of our lung cancer specialists discusses a clinical trial as a treatment option, you will have the choice to participate. If you decide to participate, you’ll continue to come to our local cancer center for treatments and you’ll be closely monitored by our cancer research team.
Lung cancer treatment has become personalized with individual treatments targeting the unique cellular characteristics of tumors. To create individualized treatment, patients must receive biomarker testing. Biomarkers are molecules that indicate normal or abnormal process taking place in your body and may be a sign of an underlying condition or disease.
RMCC is conducting a first-of-its-kind observational trial to improve testing and treatment protocols for NSCLC and is enrolling patients at all locations. The study, MYLUNG Consortium, “A Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Pragmatic Prospective Real-World Evidence Study,” brings together diverse organizations across the spectrum of drug development, therapy, and care to observe up to 12,000 NSCLC patients over a five-year period.
There are many benefits of participating in a clinical trial for lung cancer, including:
Solid safety rules and ethics bind clinical trials. There are federal rules that regulate clinical trials. It does not cost you more to be a part of a clinical trial. Importantly, volunteers can opt-out of the trial if needed.
Being a part of a clinical trial is your personal choice. Our research specialists will let you know if you are eligible to participate in a study and discuss what the treatment process will look like while in the trial.
RMCC is actively participating in research for the treatments of Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC) as well as many other types of cancer. You don’t have to go far to access these trials. They’re available at our cancer centers throughout Colorado.
If you choose to participate, keep in mind:
Learn more about the clinical trials program at Rocky Mountain Cancer Centers. And be sure to speak with your oncologist if you would like to find out if we offer a trial that would be right for you.